Allergan Stock Analysis, Valuation (NYSE:AGN)

Add to My Stocks
$155.95 $0.97 (0.63%) AGN stock closing price May 23, 2018 (Closing)
Watch Robo Advisor Video of AGN Stock Analysis
Allergan
Updated on : May 23, 2018
previous close
AGN 156 (0%)
S&P 500 2733.3 (0%)
Closing Price On: May 23, 2018
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Generic Drugs
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2018-Q1
$billion
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
-35.3%
Sector Average:
-12.2%
5 Quarter Net Profit
Net Margins
2018-Q1
%
LTM Margin
Debt/Equity Ratio
Debt:
27.19B
Debt/Equity Ratio:
 0.38
Compared to the industry
Cash Flow
Operating cash flow:
$1.46B
Net Income:
-$286.1M
Dividend Yield
AGN dividend yield:
1.81%
PROS      CONS
FCF Margin
PE Valuation
PS Valuation
Recent Growth
Operating Margins
Net Margins
High Debt Burden
ROIC
ROE
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
AGN PS :
3.3
Industry PS :
6.6
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
-1%
Return on Equity:
-2.6%
Free Cash Flow Margin:
38.8%
Double Tap To Exit Full Screen
0:00
/

Allergan Stock Analysis

3479 7 2

Watch the robo advisor video of Allergan stock analysis on Amigobulls. Our AGN analysis video highlights revenue and profit trends along with other important metrics such as valuation to find what makes the stock attractive.

Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.

Allergan plc Ordinary Shares Stock Rating 3.1/5

We at Amigobulls use various financial measures including profit margins, revenue growth and dividends for AGN stock analysis. We also use relative valuation metrics like PE ratio and price to sales ratio for Allergan valuation analysis. Allergan stock rating encapsulates our opinion about the company based on the fundamentals.

Should you buy AGN stock?

  • The price to earnings multiple of 9.3 is attractive when compared with the industry average PE ratio of 23.7.
  • AGN stock is trading at a favorable price to sales multiple of 3.3 as against the Medical-Generic Drugs industry average multiple of 6.6.
  • Allergan has a healthy FCF (Free Cash Flow) margin of 38.8%.

Should you sell AGN stock?

  • 2018 Q1 revenue growth of 2.8% YoY was meagre.
  • Over the last twelve months, Allergan posted an average operating loss margin of -35.3%.
  • Allergan posted an average Net loss of -11.9% in the last twelve months.
  • Allergan is debt laden and has a high debt/equity ratio of  0.38.
  • Allergan has a negative ROIC (Return on Invested Capital) of -1%.
  • Allergan has a negative ROE (Return On Equity) of -2.6%, indicating the company is not profitable.

Comments on this video and Allergan stock

Amigobulls Allergan stock analysis helps investors in understanding how the company's fundamentals have performed in the last few quarters. Fundamental analysis of a company is the most often used approach to find the intrinsic value of a stock.

Among the financials of the company, Allergan revenue growth along with the profit or net income give a clear picture of the financial health. Along with fundamentals, investors can utilize technical analysis to get a better idea about the price trend of Allergan stock.